v2.3.0.15
Inventories
9 Months Ended
Sep. 30, 2011
Inventories [Abstract] 
Inventories

6. INVENTORIES

Inventories are summarized as follows (in thousands):

 

     September 30,
2011
     December 31,
2010
 

Raw materials

   $ 866,413       $ 408,015   

Work in process

     175,545         454,652   

Finished goods

     295,793         341,142   
  

 

 

    

 

 

 

Total

   $ 1,337,751       $ 1,203,809   
  

 

 

    

 

 

 

As of September 30, 2011 and December 31, 2010, the joint ventures formed by Gilead and BMS, which are included in our Condensed Consolidated Financial Statements, held $971.9 million and $811.9 million in inventory, respectively, of efavirenz active pharmaceutical ingredient purchased from BMS at BMS's estimated net selling price of efavirenz.